GlassScriptPhysician profile
Neal Lippman
NPI 1487698866
$68,546.53
in general payments reported to CMS, 2019-2025
20 companies · $1,646 in 2025
The $1,646 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $28K · 2020: $17K · 2021: $8,376 · 2022: $6,267 · 2023: $4,207 · 2024: $2,877 · 2025: $1,646.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,869 · Consulting Fee: $2,538 · Travel and Lodging: $2,157 · Entertainment: $166.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,868.66 |
| Consulting Fee | $2,538.00 |
| Travel and Lodging | $2,156.91 |
| Entertainment | $166.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $49,881.62 | 2019-2025 | Aveir, Accent, Assurity |
| Medtronic, INC. | $9,836.06 | 2021-2025 | Aurora Ev-Icd Mri Surescan, Micra, Arctic Front Advance |
| Medtronic Vascular, INC. | $6,237.45 | 2019-2020 | |
| Stereotaxis INC | $835.91 | 2022-2024 | Genesis |
| Boston Scientific Corporation | $434.02 | 2019-2025 | S-Icd System Magnet, General - Therapies |
| Atricure, INC. | $314.38 | 2020-2025 | Synergy Ablation System, Atriclip Laa Exclusion System, Epi-Sense Guided Coagulation System With Visitrax |
| Davol INC. | $270.13 | 2020-2021 | |
| Biosense Webster, INC. | $195.72 | 2023-2025 | Carto 3 |
| Pfizer INC. | $81.15 | 2019-2024 | |
| Novartis Pharmaceuticals Corporation | $76.35 | 2022-2025 | |
| Janssen Pharmaceuticals, INC | $72.52 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $58.98 | 2019-2023 | |
| Impulse Dynamics (USA) INC. | $48.45 | 2023 | Optimizer |
| Preventice Services, LLC | $41.35 | 2019 | |
| Philips North America LLC | $37.84 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $37.79 | 2020-2023 | Farxiga |
| Alnylam Pharmaceuticals INC. | $24.29 | 2020 | |
| Merck Sharp & Dohme LLC | $22.81 | 2023 | Verquvo |
| Amarin Pharma, INC. | $22.43 | 2023 | |
| Convatec INC. | $17.28 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Neal Lippman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.